RAFFA WEALTH MANAGEMENT, LLC’s West Pharmaceutical WST Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.31K	Buy	12 +3	+33%	+$917	﹤0.01%	625
2026 Q1	$2.26K	Hold	9	–	–	﹤0.01%	723
2025 Q4	$2.48K	Hold	9	–	–	﹤0.01%	691
2025 Q3	$2.36K	Hold	9	–	–	﹤0.01%	669
2025 Q2	$1.97K	Hold	9	–	–	﹤0.01%	693
2025 Q1	$2.02K	Hold	9	–	–	﹤0.01%	632
2024 Q4	$2.95K	Sell	9 -3	-25%	-$944	﹤0.01%	569
2024 Q3	$3.6K	Hold	12	–	–	﹤0.01%	489
2024 Q2	$3.95K	Hold	12	–	–	﹤0.01%	581
2024 Q1	$4.75K	Hold	12	–	–	﹤0.01%	517
2023 Q4	$4.22K	Hold	12	–	–	﹤0.01%	424
2023 Q3	$4.5K	Hold	12	–	–	﹤0.01%	397
2023 Q2	$4.59K	Hold	12	–	–	﹤0.01%	411
2023 Q1	$4.16K	Hold	12	–	–	﹤0.01%	436
2022 Q4	$2.82K	Sell	12 -5	-29%	-$1.19K	﹤0.01%	497
2022 Q3	$4.18K	Hold	17	–	–	﹤0.01%	421
2022 Q2	$5.14K	Hold	17	–	–	﹤0.01%	382
2022 Q1	$6.98K	Hold	17	–	–	﹤0.01%	346
2021 Q4	$7.97K	Hold	17	–	–	﹤0.01%	336
2021 Q3	$7.22K	Hold	17	–	–	﹤0.01%	306
2021 Q2	$6.11K	Hold	17	–	–	﹤0.01%	336
2021 Q1	$4.79K	Buy	17 +3	+21%	+$859	﹤0.01%	411
2020 Q4	$3.97K	Hold	14	–	–	﹤0.01%	405
2020 Q3	$3.85K	Hold	14	–	–	﹤0.01%	372
2020 Q2	$3.18K	Buy	14 +5	+56%	+$982	﹤0.01%	386
2020 Q1	$1.37K	Buy	+9	New	+$1.39K	﹤0.01%	502
2017 Q3	–	Sell	-21	Closed	-$1.99K	–	399
2017 Q2	$1.99K	Hold	21	–	–	﹤0.01%	287
2017 Q1	$1.71K	Sell	21 -6	-22%	-$502	﹤0.01%	275
2016 Q4	$2.29K	Sell	27 -6	-18%	-$472	﹤0.01%	269
2016 Q3	$2.46K	Hold	33	–	–	﹤0.01%	263
2016 Q2	$2.5K	Hold	33	–	–	﹤0.01%	254
2016 Q1	$2.29K	Hold	33	–	–	﹤0.01%	263
2015 Q4	$1.99K	Buy	33 +4	+14%	+$241	﹤0.01%	269
2015 Q3	$1.57K	Hold	29	–	–	﹤0.01%	304
2015 Q2	$1.68K	Hold	29	–	–	﹤0.01%	298
2015 Q1	$1.75K	Buy	+29	New	+$1.54K	﹤0.01%	284

Other funds holding WST

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

BTCPP

Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's WST Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its West Pharmaceutical (WST) stake by 33% in Q2 2026, buying an estimated $917 and bringing the position to 12 shares worth $4.31K. The position accounts for ﹤0.01% of the portfolio, ranked #625.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in WST in Q1 2015 and has held it in 36 quarters since. The position peaked at $7.97K in Q4 2021. 240 funds tracked by Wall St. Rank hold WST as of Q2 2026.

RAFFA WEALTH MANAGEMENT, LLC held 12 shares of West Pharmaceutical worth $4.31K as of Q2 2026.
RAFFA WEALTH MANAGEMENT, LLC bought 3 West Pharmaceutical shares in Q2 2026, an estimated $917.
West Pharmaceutical made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #625 holding.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in West Pharmaceutical in Q1 2015 and has held it in 36 quarters since.
RAFFA WEALTH MANAGEMENT, LLC's West Pharmaceutical position peaked at $7.97K in Q4 2021.
240 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.